Literature DB >> 23513558

Heparin-induced bullous hemorrhagic dermatosis.

Samreen Choudhry1, Patricia M Fishman, Claudia Hernandez.   

Abstract

Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have been used for years in the prophylaxis and treatment of thromboembolic disease. Cutaneous reactions to heparin include hematomas, ecchymoses, erythematous plaques, nodules, skin necrosis, contact dermatitis, and urticaria, all occurring more commonly at local subcutaneous injection sites. Generalized cutaneous reactions are more rare. We report the case of a man with no known risk factors who developed intraepidermal hemorrhagic bullae on distant sites after receiving intravenous UFH for suspected pulmonary embolism. He was diagnosed with heparin-induced bullous hemorrhagic dermatosis and recovered without further complications after discontinuation of the heparin. This case reveals that widespread cutaneous reactions to heparin may occur, though they are rare.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23513558

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

Review 1.  Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature.

Authors:  Armand Russo; Susanna Curtis; Raisa Balbuena-Merle; Roxanne Wadia; Ellice Wong; Herta H Chao
Journal:  Exp Hematol Oncol       Date:  2018-07-06

2.  Hemorrhagic bullous dermatosis caused by warfarin therapy.

Authors:  Annie Ferguson; Spring Golden
Journal:  JAAD Case Rep       Date:  2016-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.